Skip to main content
PMC home page
BMC Complementary and Alternative Medicine logoLink to BMC Complementary and Alternative Medicine
. 2015 Oct 16;15:371. doi: 10.1186/s12906-015-0902-2

Chungsimyeonja-eum inhibits inflammatory responses in RAW 264.7 macrophages and HaCaT keratinocytes

Hye-Sun Lim 1,2, Kim Yeji 1, Chang-Seob Seo 1, Sae-Rom Yoo 1, Seong-Eun Jin 1, Hyeun-Kyoo Shin 1, Soo-Jin Jeong 3,4,✉
PMCID: PMC4609053  PMID: 26474855

Abstract

Background

Chungsimyeonja-eum (CSYJE) is an herbal prescription used in traditional Oriental medicine for treating cerebral infarction by reducing ischemic damage. However, the effects of CSYJE on inflammation have not been verified scientifically.

Methods

Anti-inflammatory effects of CSYJE was investigated to dertermine the inhibitory effects of CSYJE against inflammation using RAW 264.7 mouse macrophages and HaCaT human keratinocytes. To measure the effects of CSYJE on inflammatory mediators and cytokines/chemokines, we used the following methods: cell viability assay, enzyme-linked immunosorbent assay (ELISA), western blotting, immunocytochemistry. RAW 264.7 cells were pretreated with CSYJE (250, 500, or 1000 μg/mL) for 4 h and treated with lipopolysaccharide (LPS) for additional 20 h. HaCaT cells were stimulated with tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ) (TI), and CSYJE (125, 250, or 500 μg/mL) for 24 h.

Results

CSYJE suppressed the production of nitric oxide (NO, IC50 1000 μg/mL), prostaglandin E2 (PGE2, IC50 = 12.1 μg/mL), and interleukin (IL)-6 (IC50 = 248 μg/mL) in LPS-stimulated RAW 264.7 cells. CSYJE suppressed the effects of TI on the production of thymus and activation-regulated chemokine (TARC, IC50 = 330.2 μg/mL), macrophage-derived chemokine (MDC/CCL22, IC50 = 52.5 μg/mL), regulated on activation, normal T-cell expressed and secreted (RANTES/CCL5, IC50 = 372.9 μg/mL), and IL-8 (IC50 = 345.1 μg/mL) in HaCaT cells. CSYJE inhibited TI-stimulated STAT1 phosphorylation in a dose-dependent manner and nuclear translocation at 500 μg/mL in HaCaT cells.

Conclusion

Our results suggest a possible therapeutic application of CSYJE for treating inflammatory diseases.

Keywords: Chungsimyeonja-eum, Inflammation, Cytokine, Chemokine, Macrophage, Keratinocyte

Backgrounds

Inflammation constitutes multiple processes, characterized by the infiltration of inflammatory cells, such as Th2-type cells, eosinophils, mast cells, and macrophages. Of these activated cells, macrophages play a central role in managing many different pathological immune phenomena such as the over-production of inflammatory mediators. Various mediators, such as nitric oxidase, prostaglandins, and inflammatory cytokines such as interleukin (IL)-6, IL-1β and tumor necrosis factor (TNF)-α, and others induced by macrophages have important roles in inflammatory diseases [1–3].

Migration of inflammatory cells is regulated by chemokines. These are small proteins released from various cell types, which regulate the traffic of immune cells to site of inflammation or infection. Various inflammatory cytokines stimulate the expression of inflammatory chemokines [4, 5]. Among them, thymus and activation-regulated chemokine (TARC/CCL17), macrophage-derived chemokine (MDC/CCL22), and regulated on activation, normal T-cell expressed and secreted (RANTES/CCL5) are typical inflammatory chemokines and ligands for CC chemokine receptor 4 (CCR4), which is predominantly expressed on keratinocytes, Th2 lymphocytes, and basophils [6, 7]. In addition, IL-8 is another inflammatory mediator involved in allergic responses that is closely associated with the severity of chronic inflammation [8].

Extracellular binding of cytokines induces activation of the intracellular Janus kinase (JAK) that phosphorylates a specific tyrosine residue in signal transducer and activator of transcription (STAT) proteins [9], which are involved in the development and function of the immune system [10]. There are seven mammalian STAT family members that have been identified: STAT1, STAT2, STAT3, STAT4, STAT5 (STAT5A and STAT5B) and STAT6. In particular, STAT1 is a crucial molecule for the interferon (IFN)/cytokine-signaling pathways [11]. Thus, IFN-γ stimulates JAK phosphorylation, which in turn induces STAT1 phosphorylation [12]. These events eventually increase the production of chemokines including TARC, MDC, and RANTES [13, 14].

The traditional herbal formula Chungsimyeonja-eum (CSYJE) comprises nine medicinal herbs and has traditionally been used in the treatment of heart and brain diseases in Oriental medicine. Previous research reported that the water extract of CSYJE has cytoprotective effect against glutamate-induced C6 glial cell death [15]. Other studies showed that CSYJE protects against ischemic stroke and has anti-stress activity [16, 17]. However, there has been no investigation focusing on the inflammatory effects of CSYJE. Therefore, we investigated the effects and action mechanisms of CSYJE on the inflammatory mediators in RAW 264.7 macrophages and HaCaT keratinocytes.

Methods

Preparation of CSYJE water extract

The 9 crude herbal medicines forming CSYJE were purchased from Kwangmyungdang Medicinal Herbs (Ulsan, Korea). The origin of 9 herbal medicines was confirmed taxonomically by Professor Je-Hyun Lee, Dongguk University, Gyeongju, Republic of Korea. A voucher specimen (2012–KE43–1 ~ KE43–9) has been deposited at K-herb Research Center, Korea Institute of Oriental Medicine. For preparation of CSYJE water decoction, each herbal medicine was mixed as Table 1 (total weight = 5.0 kg, about 156.9 times of composition of single dose) and extracted in distilled water at 100 °C for 2 h under pressure (98 kPa) using an electric extractor (COSMOS-660; Kyungseo Machine Co., Incheon, Korea). The extract solution was filtrated using a standard sieve (No. 270, 53 μm; Chung Gye Sang Gong Sa, Seoul, Korea) and freeze-dried to give a powder sample. The yield of CSYJE extract was 13.0 % (651.4 g).

Table 1.

Herbal composition of a single dose of CSYJE

Latin name Scientific name Amount (g) Origin
Nelumbinis Semen Nelumbo nucifera Gaerhner 7.500 China
Poria Sclerotium Poria cocos Wolf 3.750 Pyeongchang, Korea
Ginseng Radix Panax ginseng C. A. Meyer 3.750 Yeongju, Korea
Astragali Radix Astragalus membranaceus Bunge 3.750 Jecheon, Korea
Scutellariae Radix Scutellaria baicalensis Georgi 2.625 Gurye, Korea
Plantaginis Semen Plantago asiatica L. 2.625 China
Liriope Tuber Liriope platyphylla Wang et Tang 2.625 Miryang, Korea
Lycii Radicis Cortex Lycium chinense Miller 2.625 China
Glycyrrhizae Radix et Rhizoma Glycyrrhiza uralensis Fischer 2.625 China
Total 1.875
Open in a new tab

High-performance liquid chromatography (HPLC) analysis of CSYJE

Quantitative analysis of the CSYJE sample was performed using a Shimadzu LC-20A Prominence HPLC system (Shimadzu Co., Kyoto, Japan) consisting of a solvent delivery unit, an on-line degasser, a column oven, an autosampler, and a photo diode array (PDA) detector. The data were acquired and processed by LabSolution software (Version 1.24 SP1). A SunFire C18 column (250 × 4.6 mm; particle size 5 μm, Waters, Milford, MA, USA), which was maintained at 40 °C, was used as the stationary phase and the mobile phases were consisted of 0.1 % (v/v) formic acid in water (A) and 0.1 % (v/v) formic acid in acetonitrile (B). The elution conditions were as follows: 10–60 % B for 0–30 min, 60–100 % B for 30–40 min, 100 % B for 40–45 min, and 100–10 % B for 45–50 min. The flow-rate was 1.0 mL/min and injection volume was 10 μL. For HPLC analysis of CSYJE, lyophilized 200 mg of CSYJE extract was dissolved in 20 mL of distilled water and then the solution was diluted to 10-fold for quantitative analysis of baicalin and wogonoside. Each solution was filtered through a SmartPor GHP 0.2 μm syringe filter (Woongki Science, Seoul, Korea) before HPLC injection.

Cell cultures

Murine macrophage RAW 264.7 and human keratinocyte HaCaT were obtained from the American Type Culture Collection (Rockville, MD) and CLS Cell Lines Service GmbH (Eppelheim, Baden-Württemberg, Germany), respectively. The cells were cultured in Dulbecco’s modified Eagle’s medium (Gibco Inc., Grand Island, NY) supplemented with 5.5 % (for RAW 264.7) or 10 % (for HaCaT) heat-inactivated fetal bovine serum (Gibco Inc.), penicillin (100 U/mL), and streptomycin (100 μg/mL) in a 5 % CO2 incubator at 37 °C.

Cytotoxicity assay

Cell viability was assessed using a Cell Counting Kit-8 assay (CCK-8 from Dojindo, Kumamoto, Japan) according to the manufacturer’s instructions. RAW 264.7 cells (3 × 103 cells/well) and HaCaT cells (1 × 103 cells/well) were incubated in 96-well plates with various concentrations of the CSYJE for 24 h. The CCK-8 reagent was added to each well, followed by incubation for an additional 4 h, and the absorbance was measured at 450 nm using a Benchmark plus microplate reader (Bio-Rad Laboratories, Hercules, CA). The percentage of viable cells was calculated using the following equation: cell viability (%) = (mean absorbance in test well/mean absorbance in control well) × 100.

Measurement of nitric oxide (NO), prostaglandin E2 (PGE2), and IL-6 production

RAW 264.7 cells were plated at a density of 2.5 × 105 cells/well in 48-well plates and incubated overnight. Cells were pretreated with various concentrations of CSYJE for 4 h and then treated with LPS (1 μg/mL) for an additional 20 h. The supernatants were collected and analyzed for the levels of NO (Griess Reagent System; Promega Corp., Madison, WI), and PGE2 and IL-6 using enzyme-linked immunosorbent assay (ELISA) kits (Cayman Chemical Co., Ann Arbor, MI for PGE2, and R&D Systems, Minneapolis, MN) according to the manufacturers’ protocols.

Measurement of chemokine production

HaCaT cells (1 × 106 cells/well) were cultured in 6-well plates. After reaching confluency, the cells were washed and treated with CSYJE in 1 mL of serum-free medium containing tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) (TI, each 10 ng/mL; R&D Systems Inc., Minneapolis, MN, USA) for 24 h. The production of TARC, MDC, RANTES, and IL-8 was determined using commercial ELISA kits (R&D Systems Inc.).

Western blotting

HaCaT cells were treated with a nontoxic concentration of CSYJE for 1 h, and then incubated in the presence of TI for 30 min. The cells were collected by centrifugation, washed twice with PBS, and suspended in an extraction lysis buffer (Sigma-Aldrich, St. Louis, MO) containing protease inhibitors. The protein concentration was determined using a protein assay reagent (Bio-Rad Laboratories, Hercules, CA) according to the manufacturer’s instructions. Equal amounts of total protein (30 μg) were resolved by 10 % sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. The membrane was incubated with blocking solution [5 % skim milk in Tris-buffered saline containing Tween 20 (TBST)], followed by an overnight incubation at 4 °C with the appropriate primary antibody. The following primary antibodies and dilution were used: anti-β-actin (1:1000 dilution; Cell Signaling, Danvers, MA), anti-STAT1, and anti-phospho-STAT1 (1:1000 dilution; Abcam, Cambridge, UK). The membranes were washed three times with TBST, and then incubated with a 1:3000 dilution of a horseradish peroxidase (HRP)-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA) for 1 h at room temperature. The membranes were again washed three times with TBST, and then developed using an enhanced chemiluminescence (ECL) kit (Thermo scientific, Rockford, IL). Image capture was performed using Chemi-Doc (Bio-Rad).

Immunofluorescence staining

HaCaT cells were seeded onto glass coverslips and incubated with TI in the absence or presence of CSYJE (500 μg/mL) for 30 min. The cells were fixed in 4 % paraformaldehyde and 100 % acetone, blocked in 0.5 % bovine serum albumin, and incubated with anti-STAT1 antibody (Cell Signaling, Danvers, MA) for 1 h at room temperature. Then, fluorescein isothiocyanate (FITC)-conjugated anti-rabbit immunoglobulin G (IgG) antibody (Invitrogen, Carlsbad, CA) was used as a secondary antibody. The immunostained cells were mounted with medium containing 4′6-diamidino-2-phenylindole (DAPI) and visualized using an Olympus FLUOVIEW FV10i confocal microscope (Tokyo, Japan).

Statistical analysis

The data are expressed as the mean ± SEM. Data were analyzed using one-way analysis of variance and Dunnett’s multiple comparisons test. Results with a P value < 0.05 were considered to be statistically significant.

Results

Identification and quantification of the marker components in CSYJE

Calibration curves of the five marker components showed good linearity with correlation coefficient (r2) ≥ 0.9998 in the different concentration ranges. Using optimized chromatography conditions, Three-dimensional chromatogram was obtained using HPLC–PDA detector and the five marker compounds were eluted within 35 min (Fig. 1). The amounts of the five marker compounds, liquiritin apioside, liquiritin, baicalin, wogonoside, and glycyrrhizin, were 1.43 ± 0.02, 2.00 ± 0.03, 22.52 ± 0.36, 7.11 ± 0.02, and 2.49 ± 0.02 mg/g, respectively.

Fig. 1.

Fig. 1

Open in a new tab

Three-dimensional chromatogram of CSYJE by HPLC-PDA. The retention times of the five marker compounds, liquiritin apioside, liquiritin, baicalin, wogonoside, and glycyrrhizin, were appeared at approximately 13.86, 14.26, 20.00, 23.18, and 28.51 min, respectively

Effects of CSYJE on cell viability of RAW 264.7 mouse macrophages and HaCaT human keratinocytes

To examine the effect of CSYJE on cell viability, RAW 264.7 cells and HaCaT cells were treated with various concentration ranging from 250 to 1000 μg/mL and 125 to 500 μg/mL of CSYJE for 24 h, respectively. As shown in Fig. 2, the survival of RAW 264.7 cells and HaCaT cells were not affected by exposure to concentration of CSYJE compared to that of the controls. Therefore, nontoxic concentrations (250, 500, or 1000 μg/mL in RAW 264.7 cells; 125, 250, or 500 μg/mL in HaCaT cells) of CSYJE were used for the subsequent experiments.

Fig. 2.

Fig. 2

Open in a new tab

Cytotoxicity of CSYJE against RAW 264.7 cells or HaCaT cells. RAW 264.7 (a) or HaCaT (b) cells were seeded onto 96-well plates and treated with various concentrations of CSYJE for 24 h. Cell viability (%) was assessed using a CCK-8 assay. The values are expressed as the mean ± SEM of three independent experiments

CSYJE inhibits production of pro-inflammatory mediators in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells

To determine the effects of CSYJE on NO and PGE2 production following LPS stimulation, RAW 264.7 cells were pretreated with various concentrations of CSYJE (0, 250, 500, or 1000 μg/mL) for 4 h and then stimulated with LPS (1 μg/mL) for an additional 20 h. CSYJE suppressed LPS-stimulated NO production in a dose-dependent manner (Fig. 3a). LPS significantly stimulated NO production by RAW 264.7 cells (14.42 ± 0.24 μM). By contrast, CSYJE significantly decreased NO production to 9.67 ± 0.09 μM (P < 0.01) at 500 μg/mL and to 5.76 ± 0.15 μM (P < 0.01) at a dose of 1000 μg/mL. PGE2 production was higher in LPS-stimulated RAW 264.7 cells than in untreated control cells, whereas CSYJE dose-dependently inhibited PGE2 production by LPS stimulation (Fig. 3b). Furthermore, LPS treatment dramatically increased IL-6 level up to 123.96 ng/mL compared with untreated control. In contrast, CSYJE significantly inhibited IL-6 production by 54.82, 55.31, and 66.89 % at 250, 500, and 1000 μg/mL, respectively (Fig. 3c).

Fig. 3.

Fig. 3

Open in a new tab

Effects of CSYJE on LPS-stimulated production of pro-inflammatory mediators in RAW 264.7 cells. Levels of NO (a), PGE2 (b), and IL-6 (c) were measured in the culture supernatants from cells treated with CSYJE and LPS. Cells were pretreated with CSYJE (250, 500, or 1000 μg/mL) for 4 h and LPS (1 μg/mL) for additional 20 h for NO, PGE2, and IL-6 assays. Cells were pretreated with CSYJE (250, 500, or 1000 μg/mL for NO and IL-6 assays, and 15.625, 31.25, 62.5, 125, 250, 500, or 1000 μg/mL for PGE2 assay) for 4 h and LPS (1 μg/mL) for additional 20 h for PGE2 assay. L-N-methylarginine (L-NMMA; (100 μM) and indomethacin (2.5 ng/mL) were used as positive control drugs. The bar graphs represent the means from three independent experiments. ## P < 0.01 vs vehicle control cells; and **P < 0.01 vs LPS-treated cells

CSYJE inhibits chemokine production in TNF-α and IFN-γ-stimulated HaCaT cells

The effects of CSYJE on TARC, MDC, RANTES, and IL-8 production levels were assessed in TI-stimulated HaCaT cells. As shown in Fig. 4a, HaCaT cells treated with TI increased the TARC level (10.78 ± 1.21 ng/mL, P < 0.01) compared with the vehicle-treated cells (0.65 ± 0.18 ng/mL). By contrast, CSYJE suppressed TI-stimulated TARC production in a dose-dependent manner. The levels were reduced by 6.44 ± 0.35 ng/mL (P < 0.01) and 1.88 ± 0.45 ng/mL (P < 0.01) using 250 and 500 μg/mL, respectively. MDC production in TI-treated cells was also increased (506.70 ± 7.27 ng/mL, P < 0.01) compared with vehicle-treated cells, but the levels were reduced significantly after treatment with CSYJE treatment (205.25 ± 16.80 ng/mL at 125 μg/mL, P < 0.01; 74.15 ± 11.59 ng/mL at 250 μg/mL, P < 0.01; and 24.34 ± 4.69 ng/mL at 500 μg/mL, P < 0.01) (Fig. 4b). TI-treated cells produced significantly more RANTES (1019.80 ± 66.97 ng/mL, P < 0.01) compared with the vehicle-treated cells. The TI-induced increase in RANTES production was significantly inhibited by CSYJE (644.18 ± 29.79 ng/mL at 250 μg/mL, P < 0.01; and 319.94 ± 68.15 ng/mL at 500 μg/mL, P < 0.01) (Fig. 4c). In addition, the level of IL-8 (2848.74 ± 98.83 ng/mL, P < 0.01) was also significantly reduced by CSYJE in a dose-dependent manner (1648.33 ± 56.81 ng/mL at 250 μg/mL, P < 0.01; and 1126.23 ± 38.02 ng/mL at 500 μg/mL, P < 0.01) (Fig. 4d). The inhibitory effects of CSYJE were similar to those of silymarin, which was used as a positive control.

Fig. 4.

Fig. 4

Open in a new tab

Effects of CSYJE on TNF-α and IFN-γ-stimulated productions of chemokines in HaCaT cells. Levels of TARC (a), MDC (b), RANTES (c), and IL-8 (d) were measured using the culture supernatants from cells treated with CSYJE (125, 250, or 500 μg/mL), and TNF-α and IFN-γ (each 10 ng/mL, TI) for 24 h. Silymarin (6.25, 12.5, or 25 μg/mL) was used as a positive control. Values were expressed as mean ± SEM of three independent experiments. ## P < 0.01 vs vehicle control cells; and **P < 0.01 vs TI-treated cells

CSYJE inhibits STAT1 phosphorylation in TNF-α and IFN-γ-stimulated HaCaT cells

TI-stimulated HaCaT cells showed markedly increased STAT1 phosphorylation compared with non-stimulated HaCaT cells. Treatment with silymarin reduced the level of STAT1 phosphorylation compared with TI stimulation alone. Treatment with CSYJE showed a dramatic reduction in STAT1 phosphorylation in a dose-dependent manner (Fig. 5a). Consistent with the results of western blotting, immunofluorescence staining revealed that CSYJE inhibited the TI-induced nuclear localization of STAT1 in HaCaT cells (Fig. 5b).

Fig. 5.

Fig. 5

Open in a new tab

Changes in TNF-α and IFN-γ-stimulated STAT1 phosphorylation in CSYJE-treated HaCaT cells. a The expression of STAT1 phosphorylation was measured using cells cotreated with CSYJE, and TNF-α and IFN-γ (each 10 ng/mL, TI) for 24 h. Silymarin (12.5, or 25 μg/mL) was used as a positive control. b Cellular localization of STAT1 was examined by immunofluorescence staining. Cells were co-treated with CSYJE (500 μg/mL), and TI for 30 min. The cells were fixed in 4 % (v/v) methanol-free formaldehyde solution (pH 7.4), stained with anti-STAT1 (red). The stained cells were mounted in medium containing DAPI (blue) and visualized under an Olympus FLUOVIEW FV 10i confocal microscope

Discussion

CSYJE, a traditional herbal fomula, is composed of 9 medicinal herbs such as Nelumbinis Semen, Poria Sclerotium, Ginseng Radix, Astragali Radix, Scutellariae Radix, Plantaginis Semen, Liriope Tuber, Lycii Radicis Cortex, and Glycyrrhizae Radix et Rhizoma and has been used to treat neuropsychiatric disease, stroke, renal tuberculosis, stomatitis, pyelitis, and cystitis in Korea [18]. The major components of the 9 herbal medicines are known as follows: flavonoids (e.g. isoquercitrin and quercetin-3-O-glucuronide) from Nelumbinis Semen [14], triterpenoids (e.g. pachymic acid and dehydropachymic acid) from Poria Sclerotium [19, 20], triterpenoids (e.g. ginsenoside Rb1 and Rb1) from Ginseng Radix [21], flavonoids (e.g. formononetin and calycosin-7-O-glucoside) from Astragali Radix [22], flavonoids (e.g. baicalin and wogonoside) from Scutellariae Radix [23], iridoids (e.g. genoiposide and genipsidic acid) form Plantaginis Semen [24, 25], steroid saponins (e.g. spicatoside A and B) form Liriope Tuber [26], phenylpropanoid (chlorogenic acid) and flavonoid (e.g. rutin) form Liriope Tuber [27], and triterpene saponin (e.g. glycyrrhizin) and flavonoids (e.g. liquiritin and liquiritigenin), from Glycyrrhizae Radix et Rhizoma [28]. Among those constituents, we tried to analyze 19 compounds, such as hyperoside, isoquercitrin, pachymic acid, ginsenoside Rb1, ginsenoside Rg1, formononetin, baicalin, baicalenin, wogonoside, wogonin, geniposide, geniposidic acid, spicatoside A, chlorogenic acid, rutin, liquiritigenin, liquiritin, liquiritin apioside, and glycyrrhizin using optimized HPLC–PDA method in CSYJE sample. Consequently, the main components of Scutellariae Radix Glycyrrhizae Radix et Rhizoma, liquiritin apioside, liquiritin, baicalin, wogonoside, and glycyrrhizin were detected. However, other components were not detected in this sample. Finally, baicalin (22.52 ± 0.36 mg/g), marker compound of Scutellariae Radix, was detected as the major compound in CSYJE extract.

In the present study, we found that CSYJE inhibited the actions of various inflammatory mediators. CSYJE inhibited production of the pro-inflammatory mediators NO and PGE2, and cytokine IL-6 in LPS-stimulated macrophages. CSYJE also inhibited the production of the chemokines TARC, MDC, RANTES, and IL-8, and suppressed STAT1 activation in TI-treated keratinocytes.

Macrophages, as innate immune cells, initiate inflammation and the immune response [29]. When challenged with LPS, macrophages are activated and release various pro-inflammatory factors, excessive release of which can result in extensive tissue damage and pathological changes. NO, an important cellular signaling molecule and pro-inflammatory mediator produced by inducible nitric oxide synthase (iNOS), plays a key role in the pathogenesis of inflammation caused by its overproduction in abnormal situations [30]. PGE2 is another important pro-inflammatory factor regulated by cyclooxygenase-2 (COX-2). Its expression is elevated in LPS-stimulated macrophages, and is associated with many chronic inflammatory diseases including cardiovascular diseases, arthritis, inflammatory bowel disease, angiogenesis, and chronic gastric ulcers [31–33]. Macrophages also release pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α, which are used to evaluate potential anti-inflammatory properties of agents against LPS-induced macrophage activation [34]. In the present study, CSYJE significantly inhibited the concentrations of NO and PGE2 in the supernatant in LPS-stimulated RAW 264.7 cells. Thus, CSYJE might reduce inflammatory responses by inhibiting IL-6 secretion.

Keratinocytes produce various chemokines, which are involved in the development of inflammatory diseases. TARC and MDC are produced by dendritic cells, endothelial cell and keratinocytes which bind and attract CCR4+ Th2 cells into inflammatory tissues [7]. Several studies have reported that there are high levels of TARC and MDC in the serum of patients with atopic dermatitis [35]. The severity of atopic dermatitis was significantly correlated with these chemokine levels [36]. RANTES is overexpressed in the keratinocytes of such patients. In addition, RANTES has a significant role in the inflammatory process of psoriasis. Here, we found that CSYJE inhibited TARC, MDC, RANTES, and IL-8 production in TI-stimulated HaCaT keratinocytes.

STAT1 is also a pivotal regulator of IFN-γ-induced immune responses [37]. The activated STAT1 pathway can modulate the expression of numerous inflammatory mediators, including chemokines [14]. Here we demonstrated that CSYJE inhibited the TI-induced phosphorylation and nuclear translocation of STAT1 in HaCaT cells. These data suggest that CSYJE might block the induction of chemokine production including TARC, MDC, and RANTES in TI-treated keratinocytes by inhibiting STAT1 activation.

Conclusions

Our present study demonstrated that CSYJE inhibited the levels of NO, PGE2, and IL-6 in LPS-stimulated RAW 264.7 cells, and reduced the production of chemokines TARC, MDC, RANTES, and IL-8 by suppressing the activation of STAT1 in TI-stimulated HaCaT cells. Further elucidation of the signaling pathways involved in the inhibition of inflammatory mediators by CSYJE is now needed to facilitate the design of therapeutic agents for inflammatory diseases.

Acknowledgement

This research was supported by a grant for “Construction of Scientific Evidence for Herbal Medicine Formulas (K14030)”, from the Korea Institute of Oriental Medicine (KIOM).

Footnotes

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

HSL and SJJ participated in the design of the study data analyses and manuscript preparation. YJK, CSS, SRY, and SEJ performed experiments. All authors read and approved the final manuscript.

References

  • 1.Coleman JW. Nitric oxide in immunity and inflammation. Int Immunopharmacol. 2001;1(8):1397–406. doi: 10.1016/S1567-5769(01)00086-8. [DOI] [PubMed] [Google Scholar]
  • 2.Duffield JS. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond) 2003;104(1):27–38. doi: 10.1042/cs1040027. [DOI] [PubMed] [Google Scholar]
  • 3.Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D. Macrophages in rheumatoid arthritis. Histol Histopathol. 2007;22(5):581–6. doi: 10.14670/HH-22.581. [DOI] [PubMed] [Google Scholar]
  • 4.Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol. 2001;107(3):535–41. doi: 10.1067/mai.2001.113237. [DOI] [PubMed] [Google Scholar]
  • 5.Pivarcsi A, Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep. 2005;5(4):284–90. doi: 10.1007/s11882-005-0068-y. [DOI] [PubMed] [Google Scholar]
  • 6.Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol. 2002;22(2):105–14. doi: 10.1615/CritRevImmunol.v22.i2.10. [DOI] [PubMed] [Google Scholar]
  • 7.Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci. 2006;43(2):75–84. doi: 10.1016/j.jdermsci.2006.06.002. [DOI] [PubMed] [Google Scholar]
  • 8.Casas C, Ribet V, Alvarez-Georges S, Sibaud V, Guerrero D, Schmitt AM, et al. Modulation of Interleukin-8 and staphylococcal flora by Avene hydrotherapy in patients suffering from chronic inflammatory dermatoses. J Eur Acad Dermatol Venereol. 2011;25(Suppl 1):19–23. doi: 10.1111/j.1468-3083.2010.03898.x. [DOI] [PubMed] [Google Scholar]
  • 9.Kwon DJ, Bae YS, Ju SM, Goh AR, Youn GS, Choi SY, et al. Casuarinin suppresses TARC/CCL17 and MDC/CCL22 production via blockade of NF-kappaB and STAT1 activation in HaCaT cells. Biochem Biophys Res Commun. 2012;417(4):1254–9. doi: 10.1016/j.bbrc.2011.12.119. [DOI] [PubMed] [Google Scholar]
  • 10.Singh RK, Dai Y, Staudinger JL, Muma NA. Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907. Int J Neuropsychopharmacol. 2009;12(5):651–65. doi: 10.1017/S1461145708009590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Takaoka A, Taniguchi T. New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism. Cancer Sci. 2003;94(5):405–11. doi: 10.1111/j.1349-7006.2003.tb01455.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tu HQ, Li XY, Tang MY, Gao JW, Xu LF, Chen ZQ, et al. Effects of tacrolimus on IFN-gamma signaling in keratinocytes: possible mechanisms by which tacrolimus affects IFN-gamma-dependent skin inflammation. Eur J Dermatol. 2011;21(1):22–31. doi: 10.1684/ejd.2011.1154. [DOI] [PubMed] [Google Scholar]
  • 13.Han EH, Hwang YP, Choi JH, Yang JH, Seo JK, Chung YC, et al. Psidium guajava extract inhibits thymus and activation-regulated chemokine (TARC/CCL17) production in human keratinocytes by inducing heme oxygenase-1 and blocking NF-kappaB and STAT1 activation. Environ Toxicol Pharmacol. 2011;32(2):136–45. doi: 10.1016/j.etap.2011.04.004. [DOI] [PubMed] [Google Scholar]
  • 14.Hongqin T, Xinyu L, Heng G, Lanfang X, Yongfang W, Shasha S. Triptolide inhibits IFN-gamma signaling via the Jak/STAT pathway in HaCaT keratinocytes. Phytother Res. 2011;25(11):1678–85. doi: 10.1002/ptr.3471. [DOI] [PubMed] [Google Scholar]
  • 15.Ko SJ, Shin YJ, Jang WS, Ha YJ, Lee SA, Ahn MS, et al. Protective Effects of Chungsimyeonja-eum on Glutamate-induced Apoptosis in C6 Glial Cells. Kor J Orient Int Med. 2010;31:54–65. [Google Scholar]
  • 16.Park SI, Lee WC. Effect of Chengsimyeunja-eum and Sunghyangjungi-san on streptozotocin-induced ischemic damaged diabetic rats. J Kor Orient Med. 2007;28:216–31. [Google Scholar]
  • 17.Yoon JH, Ko IK, Shin MS, Kim CJ, Lee CY. Anti-stress and anti-nociceptive effects of the aqueous extracts of Chungsimyeonja-eum against immobilization stress and incision pain in rats. J Orient Med Physiol. 2007;21:874–83. [Google Scholar]
  • 18.Hur J. Donguibogam. Seoul, Korea: Namsandang; 2004. p. 507. [Google Scholar]
  • 19.Li G, Xu ML, Lee CS, Woo MH, Chang HW, Son JK. Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos. Arch Pharm Res. 2004;27(8):829–33. doi: 10.1007/BF02980174. [DOI] [PubMed] [Google Scholar]
  • 20.Hoang L, Kwon SH, Kim KA, Hur JM, Kang YH, Song KS. Chemical standardization of Poria cocos. Kor J Pharmacogn. 2005;36:177–85. [Google Scholar]
  • 21.Shan SM, Luo JG, Huang F, Kong LY. Chemical characteristics combined with bioactivity for comprehensive evaluation of Panax ginseng C.A. Meyer in different ages and seasons based on HPLC-DAD and chemometric methods. J Pharm Biomed Anal. 2014;89:76–82. doi: 10.1016/j.jpba.2013.10.030. [DOI] [PubMed] [Google Scholar]
  • 22.Lee EJ, Yean MH, Jung HS, Kim JS, Kang SS. Phytochemical studies on Astragalus Root (2) – Flavonoids and a lignin. Nat Prod Sci. 2008;14:131–7. [Google Scholar]
  • 23.Tong L, Wan M, Zhang L, Zhu Y, Sun H, Bi K. Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 2012;70:6–12. doi: 10.1016/j.jpba.2012.03.051. [DOI] [PubMed] [Google Scholar]
  • 24.Kim BH, Park KS, Chang IM. Elucidation of anti-inflammatory potencies of Eucommia ulmoides bark and Plantago asiatica seeds. J Med Food. 2009;12(4):764–9. doi: 10.1089/jmf.2008.1239. [DOI] [PubMed] [Google Scholar]
  • 25.Oh JS, Lee JG, Jung HW, Choi JY, Choi EH, Kim DC, et al. Isolation of melanin biosynthesis inhibitory compounds from the seeds of Plantago asiatica L. Kor J Pharmacogn. 2007;38:376–81. [Google Scholar]
  • 26.Shin JS. Saponin composition of Liriope platyphlla and Ophiopogon japonicus. Kor J Srop Sci. 2002;47:236–9. [Google Scholar]
  • 27.Mocan A, Vlase L, Vodnar DC, Bischin C, Hanganu D, Gheldiu AM, et al. Polyphenolic content, antioxidant and antimicrobial activities of Lycium barbarum L. and Lycium chinense Mill. leaves. Molecules. 2014;19(7):10056–73. doi: 10.3390/molecules190710056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zhang Q, Ye M. Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice) J Chromatogr A. 2009;1216(11):1954–69. doi: 10.1016/j.chroma.2008.07.072. [DOI] [PubMed] [Google Scholar]
  • 29.Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol. 1995;35:655–77. doi: 10.1146/annurev.pa.35.040195.003255. [DOI] [PubMed] [Google Scholar]
  • 30.Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15(6):252–9. doi: 10.1007/s10787-007-0013-x. [DOI] [PubMed] [Google Scholar]
  • 31.Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002;53:35–57. doi: 10.1146/annurev.med.53.082901.103952. [DOI] [PubMed] [Google Scholar]
  • 32.Rocca B, FitzGerald GA. Cyclooxygenases and prostaglandins: shaping up the immune response. Int Immunopharmacol. 2002;2(5):603–30. doi: 10.1016/S1567-5769(01)00204-1. [DOI] [PubMed] [Google Scholar]
  • 33.Singh VP, Patil CS, Jain NK, Kulkarni SK. Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats. Pharmacology. 2004;72(2):77–84. doi: 10.1159/000079135. [DOI] [PubMed] [Google Scholar]
  • 34.Ci X, Ren R, Xu K, Li H, Yu Q, Song Y, et al. Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells. Inflammation. 2010;33(2):126–36. doi: 10.1007/s10753-009-9166-7. [DOI] [PubMed] [Google Scholar]
  • 35.Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy. 2005;60(5):685–8. doi: 10.1111/j.1398-9995.2005.00774.x. [DOI] [PubMed] [Google Scholar]
  • 36.Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci. 2004;34(3):201–8. doi: 10.1016/j.jdermsci.2004.01.001. [DOI] [PubMed] [Google Scholar]
  • 37.Ju SM, Song HY, Lee SJ, Seo WY, Sin DH, Goh AR, et al. Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose via blockade of NF-kappaB and STAT1 activation in the HaCaT cells. Biochem Biophys Res Commun. 2009;387(1):115–20. doi: 10.1016/j.bbrc.2009.06.137. [DOI] [PubMed] [Google Scholar]

Articles from BMC Complementary and Alternative Medicine are provided here courtesy of BMC

RESOURCES